Waverly Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1M | Buy |
230,234
+6,144
| +3% | +$429K | 0.18% | 116 |
|
|
2025
Q1 | $16.5M | Buy |
224,090
+199,935
| +828% | +$14.7M | 0.2% | 106 |
|
|
2024
Q4 | $1.58M | Buy |
24,155
+15,881
| +192% | +$1.04M | 0.02% | 431 |
|
|
2024
Q3 | $645K | Sell |
8,274
-397
| -5% | -$30.9K | 0.01% | 533 |
|
|
2024
Q2 | $676K | Buy |
8,671
+710
| +9% | +$55.4K | 0.01% | 508 |
|
|
2024
Q1 | $539K | Buy |
7,961
+2,365
| +42% | +$160K | 0.01% | 465 |
|
|
2023
Q4 | $377K | Sell |
5,596
-70
| -1% | -$4.72K | 0.01% | 335 |
|
|
2023
Q3 | $384K | Buy |
5,666
+750
| +15% | +$50.8K | 0.02% | 290 |
|
|
2023
Q2 | $352K | Buy |
+4,916
| New | +$352K | 0.02% | 278 |
|
|
2014
Q4 | – | Sell |
-244
| Closed | -$9K | – | 436 |
|
|
2014
Q3 | $9K | Hold |
244
| – | – | ﹤0.01% | 498 |
|
|
2014
Q2 | $9K | Sell |
244
-198
| -45% | -$7.3K | ﹤0.01% | 465 |
|
|
2014
Q1 | $14K | Hold |
442
| – | – | 0.01% | 369 |
|
|
2013
Q4 | $13K | Buy |
+442
| New | +$13K | ﹤0.01% | 518 |
|